Alaunos Therapeutics (TCRT)

• Market cap: $6.45M
• 1 day: -3.34%
• 5 days: -0.69%
• 1 month: -11.35%
• 3 months: 2.85%
• 6 months: -9.4%
• Year to date: -11.89%
• 1 year: -0.34%
• 5 years: -99.44%
• 10 years: -99.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Employees: 1